Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
HAR enters its October 23 earnings date with the borrow market telling a sharply different story from last week, as a brief spike in borrowing costs has reversed hard and lending availability has exploded wider.
The most striking development since the previous note is what happened to cost-to-borrow on October 9. The rate jumped to 6.35%, more than seven times the level seen just two days earlier. It has since collapsed back to 0.87%, close to where it was through most of September. That kind of intraday or single-session dislocation in a JSE-listed miner typically reflects a short-dated demand burst, someone needing to borrow shares quickly, rather than a structural shift in bearish conviction. More tellingly, availability has swung from around 860% of estimated short interest last week to 8,168% now, meaning there are more than eighty shares available to borrow for every one currently lent out. The 52-week low in availability was 187%, so the lending pool is about as loose as it gets for this name. Borrow conditions have eased dramatically, not tightened, since the prior note.
The ORTEX short score has continued to drift higher, reaching 33.5 on October 12 from 30.2 a week earlier. That is a meaningful move in direction, but the absolute level remains well below any threshold that would indicate genuine short-side pressure. The combined score of 26.6 is lower still. Short interest is not the story here: the market is not making an aggressive directional bet against HAR ahead of results.
What has changed more materially is the stock itself. HAR has fallen a further 2.7% on the week to ZAR 273.74, extending the one-month loss to 18.4%. That move sits in contrast to its closest JSE peer, GFI, which gained 1.6% on the week, and IMP, which added 2.9% in a single session. The divergence from JSE-listed peers is widening, consistent with the pattern flagged in recent notes: HAR's higher-cost South African underground exposure leaves it more exposed to margin compression when the rand or the gold price moves against it. The valuation picture reflects some of that pain. The trailing PE has compressed to 4.2 and the price-to-book to 1.4, with both multiples having fallen meaningfully over the past month. The EV/EBITDA of 2.7 looks cheap in isolation, but the 30-day direction on that multiple is also lower.
On factor scores, the EV/EBIT rank at the 94th percentile confirms the apparent cheapness on an operational earnings basis. Short-term earnings momentum is strong, ranking in the 81st percentile on a 30-day basis, though the 90-day picture is weaker at the 29th percentile, a split that suggests recent estimate revisions have been positive but the broader trend is still cautious. Analyst data is too stale to be cited here, with the most recent coverage predating 2021 by years.
The institutional register has seen modest recent activity. BlackRock added around 316,000 shares as of September 30, while Van Eck and Vanguard both nudged their positions slightly higher. Those are incremental flows rather than conviction-sized moves. The dominant holders, Public Investment Corporation at 16.1% and African Rainbow Minerals at 10.8%, reported no change as of June 30. Insider activity through October has been entirely grant-related, executive director HE Mashego receiving share awards on October 2, with no open-market purchases or sales.
The last time HAR reported results, on August 27, the stock fell 6.9% on the day and extended that to an 8.6% loss over the following five sessions. With the next print nine days away, the key question is whether a further 18% drawdown ahead of results has already discounted whatever the market fears, or whether the operational cost picture will deliver another downside surprise at current gold and rand levels.
See the live data behind this article on ORTEX.
Open HAR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
